Pfizer

Image

JÁNOS KOROM/WIKIMEDIA COMMONS

Pfizer’s COVID Cash Powers A ‘Marketing Machine’ On The Hunt For New Supernovas

Pfizer is sinking billions in profits from COVID-19 into developing and marketing potential new treatment blockbusters for conditions like migraines, sickle cell disease and obesity.

Nov 8, 2022

Image

A COLOGUARD COLORECTAL SCREENING TEST PACKAGE, READY FOR RETURN TO EXACT SCIENCES/WIKIMEDIA CREATIVE COMMONS/GNESENER1900

Eugene Man Sues Cologuard Maker Claiming Fraud, Breach Of Contract

Lawsuit by former longtime sales representative claims Exact Sciences Corp. made false promises in order to hire him, then forced him to resign.

Sep 13, 2022
Premium

Image

FRITZ LIEDTKE/OREGON HEALTH & SCIENCE UNIVERSITY

How Pfizer Won The Pandemic, Reaping Outsize Profit And Influence

Pfizer's success in developing COVID medicines has given the drugmaker unusual weight in determining U.S. health policy.

Jul 5, 2022

Image

JÁNOS KOROM/WIKIMEDIA COMMONS

Pfizer CEO Pushes Yearly Shots For COVID. Not So Fast, Experts Say.

When Albert Bourla said all Americans will need a second booster shot, some experts saw his claim as self-serving.

Mar 22, 2022

Image

Latinos were among the patients at an OHSU vaccination clinic in Hillsboro in May. | JOSH ANDERSEN/OHSU

The White House Says Boosters for All. Here’s What You Need to Know.

The rollout would begin the week of Sept. 20 for U.S. residents 18 and older who received their second shot of the Moderna or Pfizer-BioNTech vaccines at least eight months previously.

Aug 18, 2021

Image

FRITZ LIEDTKE/OREGON HEALTH & SCIENCE UNIVERSITY

Pfizer CEO To Public: Just Trust Us On The Covid Booster

As pharmaceutical companies declare a need for boosters, scientists and doctors emphasize that there’s no proof yet.

Aug 13, 2021

Image

Pfizer is one of the world's largest drugmakers./Mat Napo on Unsplash

Pfizer Court Fight Could Legalize Medicare Copays And Unleash ‘Gold Rush’ in Sales

A Pfizer win in a lawsuit against the federal government could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices, say health policy analysts.

Jul 29, 2021

Image

FRITZ LIEDTKE/OREGON HEALTH & SCIENCE UNIVERSITY

Analysis: Necessary Or Not, COVID Booster Shots Are Probably On The Horizon

Booster shots are likely to be here before long because of the outdated, 60-year-old basic standard the Food and Drug Administration uses to authorize medicines for sale.

Jul 21, 2021

Image

FRITZ LIEDTKE/OREGON HEALTH & SCIENCE UNIVERSITY

Not All Experts Are Ready to Vaccinate Kids Against COVID

The Centers for Disease Control and Prevention is set to meet on Friday to discuss whether rare instances of a heart disorder merit changing its recommendations for vaccinating teenagers with the Pfizer vaccine.

Jun 17, 2021

Image

OHSU receiving a shipment of Pfizer BioNTEch COVID-19 vaccine. | OHSU/FRITZ LIEDTKE

Oregon Stockpiles Vaccines Amid Push To Increase Vaccination Rate

The state has enough supplies of Pfizer, Moderna and Johnson & Johnson doses to last about 80 days at current vaccination pace.

Jun 10, 2021
Premium